Patient Group Disclosures | Takeda Pharmaceuticals
Patient Group Disclosures
Patient Groups – or patient advocacy groups and patient organizations – are important partners for Takeda. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community. We support patient organizations in our therapeutic areas through sponsorships, grants and donations. In keeping with our commitment to ensure responsible business practices, Takeda believes transparency in our funding decisions is vital to building and maintaining trust with our stakeholders.
Takeda
2023
2022
2021
2020
2019
Shire
Takeda
2023
2022
2021
2020
Shire
Takeda
2023
2022
2021
2020
Shire
No payments made in 2020
Takeda
2023
2022
2021
2020
2019
Shire
Takeda
2023
2022
2021
2020
2019
Shire
Takeda
2023
2022
2021
2020
2019
Shire
Takeda
2023
2022
2021
2020
2019
Shire
2023
2022
- Given the current situation in Ukraine, EFPIA decided to suspend the disclosure requirements in that country for the 2023 disclosure of 2022 data
2021
- Given the current situation in Ukraine, EFPIA decided to suspend the disclosure requirements in that country for the 2022 disclosure of 2021 data
2020
2019